Hyperleptinemia May Protect From Cardio-Vascular Complications: A Small Georgian Study
DOI:
https://doi.org/10.3889/oamjms.2014.106Keywords:
Leptin, Anthropometric parameters, Body composition, Cardio-vascular risk factors, Lipid panelAbstract
BACKGROUND AND AIM: Leptin was assessed to play a coordinating role in obesity and its cardio-vascular complications, however the findings are conflicting and further clinical investigation is required. The aim of the present study was to evaluate the association of serum leptin with cardio-vascular risk factors in different body mass index and age groups.
MATERIALS AND METHODS:Â One hundred and forty nine female patients were enrolled in the study and divided into groups according to body mass index (BMI) and age. Following measurements were carried out: height, weight, BMI, waist circumference, blood pressure. Venous blood sample was obtained for plasma leptin, insulin, glucose and lipid profile analysis. Insulin resistance index was calculated for each patient. Body fat distribution was measured using Dual energy X-ray Absorbtiometry.
RESULTS: The lowest leptin concentration was observed in overweight patients, the highest concentration was seen in obese patients. The difference between leptin levels were not observed in age groups. Leptin positively correlated with high density lipoprotein cholesterol levels in obese and elder patients.
CONCLUSION: Leptin might act as a preventive measure for cardiovascular complications only in the presence of sufficient amount of fat mass. Further studies are warranted in order to support these results.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Shah NR, Braverman ER. Measuring Adiposity in Patients: The Utility of Body Mass Index (BMI), Percent Body Fat, and Leptin. PLoS One. 2012; 7: e33308. DOI: https://doi.org/10.1371/journal.pone.0033308
Ren J. Leptin and hyperleptinemia - from friend to foe for cardiovascular function. J Endocrinol. 2004;181(1):1-10. DOI: https://doi.org/10.1677/joe.0.1810001
Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes. 1996; 45: 1455-1462. DOI: https://doi.org/10.2337/diab.45.11.1455
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, and Caro JC. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1999; 334: 292-295. DOI: https://doi.org/10.1056/NEJM199602013340503
Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A. Leptin-replacement therapy for lipodistrophy. N Engl J Med. 2002; 346: 570-578. DOI: https://doi.org/10.1056/NEJMoa012437
Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S, Lechler RI, DePaoli AM, O'Rahilly S. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002; 110: 1093-1103. DOI: https://doi.org/10.1172/JCI0215693
Schutte AE, Schutte R. Leptin: a cardiovascular perspective. JEMDSA. 2012; 17: 72-76. DOI: https://doi.org/10.1080/22201009.2012.10872280
Silver DL, Jiang X, Tall AR. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob Mice. J Biol Chem. 1999; 274: 4140-4146. DOI: https://doi.org/10.1074/jbc.274.7.4140
Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest. 2000; 105: 1243-1252. DOI: https://doi.org/10.1172/JCI8341
Cohen B, Novick D, Rubenstein M. Modulation of insulin activities by leptin. Science. 1997; 274: 1185- 1188. DOI: https://doi.org/10.1126/science.274.5290.1185
De Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M, Dowse G, Alberti KG. Hyperleptinemia: the missing link in metabolic syndrome. Diab Med. 1997; 14: 200-208. DOI: https://doi.org/10.1002/(SICI)1096-9136(199703)14:3<200::AID-DIA336>3.0.CO;2-V
Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, Bloom S, Stevenson JC.. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol. 1998; 18: 928-933. DOI: https://doi.org/10.1161/01.ATV.18.6.928
Adami GF, Civalleri D, Cella F, Marinari G, Camerini G, Papadia F, Scopinaro N. Relationships of serum leptin to clinical and anthropometric findings in obese patients. Obes Surg. 2002; 12: 623-627. DOI: https://doi.org/10.1381/096089202321019576
World Health Organization. Global Strategy on Diet, Physical Activity and Health. What is overweight and obesity? (at site http://www.who.int/dietphysicalactivity/childhood_what/en/)
Wallace TM, Levy JC, Matthews DR. Use and Abuse of HOMA Modeling. Diabetes Care. 2004; 27: 1487–1495. DOI: https://doi.org/10.2337/diacare.27.6.1487
Andreasson, A. N., Undén, AL., Elofsson, S., Brismar, K. Leptin and adiponectin: Distribution and associations with cardiovascular risk factors in men and women of the general population. Am J Hum Biol. 2012; 24: 595-601. DOI: https://doi.org/10.1002/ajhb.22279
Liuzzi A, Savia G, Tagliaferri M, Lucantoni R, Berselli ME, Petroni ML, De Medici C, Viberti GC. Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord. 1999; 23: 1066-1073. DOI: https://doi.org/10.1038/sj.ijo.0801036
Al-Shoumer KA, Al-Asousi AA, Doi SA, Vasanthy BA. Serum leptin and its relationship with metabolic variables in Arabs with type 2 diabetes mellitus. Ann Saudi Med. 2008; 28: 367-370. DOI: https://doi.org/10.5144/0256-4947.2008.367
GarcÃa-Lorda P, Bulló M, Vilà R, del Mar Grasa M, Alemany M, Salas-Salvadó J. Leptin concentrations do not correlate with fat mass nor with metabolic risk factors in morbidly obese females. Diabetes Nutr Metab. 2001;14:329-36.
Brydon L, O'Donnell K, Wright CE, Wawrzyniak AJ, Wardle J, Steptoe A. Circulating leptin and stress-induced cardiovascular activity in humans. Obesity (Silver Spring). 2008; 16: 2642-2647. DOI: https://doi.org/10.1038/oby.2008.415
Brydon L, Wright CE, O'Donnell K, Zachary I, Wardle J, Steptoe A. Stress-induced cytokine responses and central adiposity in young women. Int J Obes (Lond). 2008; 32: 443-450. DOI: https://doi.org/10.1038/sj.ijo.0803767
Alvarez-Aguilar C, Mondragón-Jiménez LI. Hyperleptinemia as a risk factor in obesity-related hypertension. Med Clin (Barc). 2004; 123: 766-769. DOI: https://doi.org/10.1157/13069809
Benlian P, Cansier C, Hennache G, Khallouf O, Bayer P, Duron F, Carrat F, Couderc R, Chazouillères O, Bardet J, Bouchard P, Poupon R, Masliah J, Béréziat G. Comparison of new method for the direct and simultaneous assessment of LDL and HDL cholesterol with ultracentrifugation and established methods. Clin Chem. 2000; 46: 493–505. DOI: https://doi.org/10.1093/clinchem/46.4.493
Lonnqvist F, Wennlund A, Arner P. Relationship between circulating leptin and peripheral fat distribution in obese subjects. Int J Obes Relat Metab Disord. 1997; 21: 255-260. DOI: https://doi.org/10.1038/sj.ijo.0800394
Hodge AM, Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG. Leptin and other components of the Metabolic syndrome in Mauritius- a factor analysis. Int J Obes Relat Metab Disord. 2001; 25: 126-131. DOI: https://doi.org/10.1038/sj.ijo.0801522
Ryan AS, Nicklas BJ. Age-related changes in fat deposition in mid-thigh muscle in women: relationships with metabolic cardiovascular disease risk factors. Int J Obes Relat Metab Disord. 1999; 23: 126-132. DOI: https://doi.org/10.1038/sj.ijo.0800777
HaluzÃk M, Fiedler J, NedvÃdková J, Ceska R. Serum leptin levels in patients with hyperlipidemias. Nutrition. 2000; 16: 429-433. DOI: https://doi.org/10.1016/S0899-9007(00)00288-4
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0